BioAge Labs
BioAge Labs is a clinical‑stage biopharmaceutical company focused on developing therapeutics for metabolic diseases by targeting the biology of human aging.
Company facts
- Founded
- 2015
- Employees
- 200
- Headquarters
- United States
- CEO
- Kristen Fortney
- Type
- Small Business
About
BioAge Labs is a clinical‑stage biopharmaceutical company focused on developing therapeutics for metabolic diseases by targeting the biology of human aging. Its lead candidate, BGE‑102, is a potent, orally available, brain‑penetrant small‑molecule NLRP3 inhibitor currently in Phase 1 trials for cardiovascular risk and retinal disorders. The company is also advancing long‑acting injectable and oral APJ agonists for obesity, leveraging a proprietary discovery platform built on human longevity data to identify key pathways in metabolic aging. BioAge offers employees the chance to work on cutting‑edge, age‑targeted drug programs within a supportive, inclusive environment. Competitive compensation, comprehensive health and wellness benefits, 401(k) matching, and generous professional‑development resources underscore the company’s commitment to attracting top talent and fostering career growth.
Open positions
Director, Clinical Supply Chain (or Senior)
We are seeking an experienced Director, Supply Chain (or Senior Director) This is a fully remote position, and the successful candidate can live in any of the continental US states. Position Summary: Reporting to the…
Senior Director, Clinical Operations
BioAge Labs is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. We are seeking an experienced Senior Director of…